Publications and posters - Oncoinvent

Home » Technology » Publications and posters

Publications

Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland Ø, Bønsdorff TB, Larsen R; J Labelled Comp Radiopharm. 2018 May 30;61(6):472-486.

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma. Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH. PLoS One. 2016 Oct 24;11(10)

Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH. Translational Oncology. 2018 Jan 27;11:259-267

Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution. Westrøm S, Generalov R, Bønsdorff TB, Larsen RH. Nuclear Medicine and Biology. 2017 Apr 26;51:1-9

Release and retention of 212Pb from 224Ra-labeled microparticles. Napoli E, Westrøm S, Bønsdorff TB, Bruland Ø, Larsen R.; The Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting in Philadelphia, USA

Posters

A primary activity standard for the alpha-emitting radionuclide Ra-224 (SNMMI 2019)

Biodistribution of RA-224 and its progeny PB-212 after intraperitoneal infusion of RA-224 labeled microparticles in rats (AACR 2019)

Alpha-Emitting Radiopharmaceutical for IP Therapy of Peritoneal Metastases (EANM2018)

Preclinical Evaluation of a Novel Alpha-Particle (ESGO7-0822)

Board of Directors

Newsletter subscription

Reports and presentations

Largest shareholders

+47 22 18 33 05

Oncoinvent AS Gullhaugveien 7 0484 Oslo Norway

© Oncoinvent. All rights reserved. Design by Anagram Design AS

/* ----------------------------------------- */ /* View slug: publications-view - start */ /* ----------------------------------------- */ .no-show { display:none; } .yearselect { -webkit-appearance: none; -moz-appearance: none; appearance: none; background: #1f2548; color: #ffffff; height: 40px; width: 100%; border: 0; outline: 1px inset #1f2548; outline-offset: -1px; } .select-icon { position: relative; cursor: pointer; } .select-icon:after { content:""; font-family: FontAwesome; color: #fff; position: absolute; right: -10px; top: -8px; z-index: 91; width: 40px; height: 40px; pointer-events: none; } .testclss { background:pink; width: 72%; } .grid-100 p.attachment { margin-bottom:1em; font-size:14px; } .grid-100 p.attachment a:before { font-family: "FontAwesome"; content: ""; display: inline-block; padding-right: .5em; vertical-align: middle; margin-left: -1.5em; color: #e6332a; } .grid-100 p.attachment a:hover { text-decoration: underline; } .rslt { padding-left: 27%; margin-top: -40px; } .tablet-grid-95:first-of-type { } @media only screen and (max-width: 768px) { /* For mobile phones: */ .rslt { padding-left: 0 !important; margin-top: 20px !important; } } /* ----------------------------------------- */ /* View slug: publications-view - end */ /* ----------------------------------------- */ /* ----------------------------------------- */ /* View slug: posters-view - start */ /* ----------------------------------------- */ .no-show { display:none; } .yearselect { -webkit-appearance: none; -moz-appearance: none; appearance: none; background: #1f2548; color: #ffffff; height: 40px; width: 100%; border: 0; outline: 1px inset #1f2548; outline-offset: -1px; } .select-icon { position: relative; cursor: pointer; } .select-icon:after { content:""; font-family: FontAwesome; color: #fff; position: absolute; right: -10px; top: -8px; z-index: 91; width: 40px; height: 40px; pointer-events: none; } .testclss { background:pink; width: 72%; } .grid-100 p.attachment { margin-bottom:1em; font-size:14px; } .grid-100 p.attachment a:before { font-family: "FontAwesome"; content: ""; display: inline-block; padding-right: .5em; vertical-align: middle; margin-left: -1.5em; color: #e6332a; } .grid-100 p.attachment a:hover { text-decoration: underline; } .rslt { padding-left: 27%; margin-top: -40px; } .tablet-grid-95:first-of-type { } @media only screen and (max-width: 768px) { /* For mobile phones: */ .rslt { padding-left: 0 !important; margin-top: 20px !important; } } /* ----------------------------------------- */ /* View slug: posters-view - end */ /* ----------------------------------------- */